Evaluation of canonical siRNA and Dicer substrate RNA for inhibition of hepatitis C virus genome replication - A comparative study

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Carneiro, Bruno ^a,b   Braga, Ana Cláudia Silva ^a   Batista, Mariana Nogueira ^a   Harris, Mark ^b   Rahal, Paula ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; DICER SUBSTRATE SMALL INTERFERING RNA; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 4B; NONSTRUCTURAL PROTEIN 5A; NONSTRUCTURAL PROTEIN 5B; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; 5' UNTRANSLATED REGION; VIRAL PROTEIN; VIRUS RNA;

5' UNTRANSLATED REGION; ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; GENE REPLICATION; HEPATITIS C; NONHUMAN; REPLICON; VIRUS GENOME; VIRUS INHIBITION; VIRUS REPLICATION; GENETIC TRANSFECTION; GENETICS; HEPACIVIRUS; HUMAN; PROCEDURES; TUMOR CELL LINE;

HEPATITIS C VIRUS;

5' UNTRANSLATED REGIONS; CELL LINE, TUMOR; GENOME, VIRAL; HEPACIVIRUS; HUMANS; REPLICON; RNA, SMALL INTERFERING; RNA, VIRAL; TRANSFECTION; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

EID: 84923374490     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0117742     Document Type: Article

References (55)

1. Roche B, Samuel D (2012) Hepatitis C virus treatment pre- and post-liver transplantation. Liver Int 32 Suppl 1: 120-128. doi: 10.1111/j.1478-3231.2011.02714.x PMID: 22212582
2. Ly KN, Xing J, Klevens RM, Jiles RB, Ward JW, et al. (2012) The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Ann Intern Med 156: 271-278. doi: 10.7326/0003-4819-156-4-201202210-00004 PMID: 22351712
3. Lavanchy D (2011) Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect 17: 107-115. doi: 10.1111/j.1469-0691.2010.03432.x PMID: 21091831
4. Ashfaq UA, Javed T, Rehman S, Nawaz Z, Riazuddin S (2011) An overview of HCV molecular biology, replication and immune responses. Virol J 8: 161. doi: 10.1186/1743-422X-8-161 PMID: 21477382
5. Giannini C, Bréchot C (2003) Hepatitis C virus biology. Cell Death Differ 10 Suppl 1: S27-38. PMID: 12655344
6. Who (2014) Guidelines for the screening, care and treatment of persons with hepatitis c infection.
7. Younossi Z, Henry L (2014) The impact of the new antiviral regimens on patient reported outcomes and health economics of patients with chronic hepatitis C. Dig Liver Dis 46S5: S186-S196.
8. Khaliq S, Khaliq SA, Zahur M, Ijaz B, Jahan S, et al. (2010) RNAi as a new therapeutic strategy against HCV. Biotechnol Adv 28: 27-34. doi: 10.1016/j.biotechadv.2009.08.004 PMID: 19729057
9. Dallas A, Ilves H, Ma H, Chin DJ, Maclachlan I, et al. (2014) Inhibition of hepatitis C virus in chimeric mice by short synthetic hairpin RNAs: sequence analysis of surviving virus shows added selective pressure of combination therapy. J Virol 88: 4647-4656. doi: 10.1128/JVI.00105-14 PMID: 24478422
10. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, et al. (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391: 806-811. PMID: 9486653
11. Hannon GJ (2002) RNA interference. Nature 418: 244-251. PMID: 12110901
12. Harborth J, Elbashir SM, Bechert K, Tuschl T, Weber K (2001) Identification of essential genes in cultured mammalian cells using small interfering RNAs. J Cell Sci 114: 4557-4565. PMID: 11792820
13. Pecot C V, Calin GA, Coleman RL, Lopez-Berestein G, Sood AK (2011) RNA interference in the clinic: challenges and future directions. Nat Rev Cancer 11: 59-67. doi: 10.1038/nrc2966 PMID: 21160526
14. Elbashir SM, Martinez J, Patkaniowska a, Lendeckel W, Tuschl T (2001) Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J 20: 6877-6888. PMID: 11726523
15. Kapadia SB, Brideau-Andersen A, Chisari F V (2003) Interference of hepatitis C virus RNA replication by short interfering RNAs. Proc Natl Acad Sci U S A 100: 2014-2018. PMID: 12566571
16. Randall G, Grakoui A, Rice CM (2003) Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs. Proc Natl Acad Sci U S A 100: 235-240. PMID: 12518066
17. Wilson JA, Jayasena S, Khvorova A, Sabatinos S, Rodrigue-Gervais IG, et al. (2003) RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cells. Proc Natl Acad Sci U S A 100: 2783-2788. PMID: 12594341
18. Kim D-H, Behlke M a, Rose SD, Chang M-S, Choi S, et al. (2005) Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy. Nat Biotechnol 23: 222-226. PMID: 15619617
19. Pichu S, Krishnamoorthy S, Zhang B, Jing Y, Shishkov A, et al. (2012) Dicer-substrate siRNA inhibits tumor necrosis factor alpha secretion in Kupffer cells in vitro: In vivo targeting of Kupffer cells by siRNA-liposomes. Pharmacol Res 65: 48-55. doi: 10.1016/j.phrs.2011.09.001 PMID: 21933712
20. Snead NM, Wu X, Li A, Cui Q, Sakurai K, et al. (2013) Molecular basis for improved gene silencing by Dicer substrate interfering RNA compared with other siRNA variants. Nucleic Acids Res 41: 6209-6221. doi: 10.1093/nar/gkt200 PMID: 23620279
21. Bartenschlager R, Lohmann V (2000) Replication of the hepatitis C virus. Baillieres Best Pract Res Clin Gastroenterol 14: 241-254. PMID: 10890319
22. Konishi M, Wu CH, Kaito M, Hayashi K, Watanabe S, et al. (2006) siRNA-resistance in treated HCV replicon cells is correlated with the development of specific HCV mutations. J Viral Hepat 13: 756-761. PMID: 17052275
23. Wyles DL, Kaihara KA, Korba BE, Schooley RT, Beadle JR, et al. (2009) The Octadecyloxyethyl Ester of (S) -9- [3-Hydroxy-2- (Phosphonomethoxy) Propyl] Adenine Is a Potent and Selective Inhibitor of Hepatitis C Virus Replication in Genotype 1A, 1B, and 2A Replicons. 53: 2660-2662. doi: 10.1128/AAC.01546-08 PMID: 19289518
24. Tscherne DM, Jones CT, Evans MJ, Lindenbach BD, McKeating JA, et al. (2006) Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry. J Virol 80: 1734-1741. PMID: 16439530
25. Blight KJ, McKeating JA, Rice CM (2002) Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol 76: 13001-13014. PMID: 12438626
26. Ross-Thriepland D, Amako Y, Harris M (2013) The C terminus of NS5A domain II is a key determinant of hepatitis C virus genome replication, but is not required for virion assembly and release. J Gen Virol 94: 1009-1018. doi: 10.1099/vir.0.050633-0 PMID: 23324467
27. Amako Y, Sarkeshik A, Hotta H, Yates J, Siddiqui A (2009) Role of oxysterol binding protein in hepatitis C virus infection. J Virol 83: 9237-9246. doi: 10.1128/JVI.00958-09 PMID: 19570870
28. Rose SD, Kim D-H, Amarzguioui M, Heidel JD, Collingwood MA, et al. (2005) Functional polarity is introduced by Dicer processing of short substrate RNAs. Nucleic Acids Res 33: 4140-4156. PMID: 16049023
29. Macdonald A, Crowder K, Street A, McCormick C, Saksela K, et al. (2003) The hepatitis C virus non-structural NS5A protein inhibits activating protein-1 function by perturbing ras-ERK pathway signaling. J Biol Chem 278: 17775-17784. PMID: 12621033
30. Mruk DD, Cheng CY (2011) Enhanced chemiluminescence (ECL) for routine immunoblotting: An inexpensive alternative to commercially available kits. Spermatogenesis 1: 121-122. PMID: 22319660
31. Jackson AL, Bartz SR, Schelter J, Kobayashi S V, Burchard J, et al. (2003) Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol 21: 635-637. PMID: 12754523
32. Scacheri PC, Rozenblatt-Rosen O, Caplen NJ, Wolfsberg TG, Umayam L, et al. (2004) Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells. Proc Natl Acad Sci U S A 101: 1892-1897. PMID: 14769924
33. Semizarov D, Frost L, Sarthy A, Kroeger P, Halbert DN, et al. (2003) Specificity of short interfering RNA determined through gene expression signatures. Proc Natl Acad Sci U S A 100: 6347-6352. PMID: 12746500
34. Korf M, Jarczak D, Beger C, Manns MP, Krüger M (2005) Inhibition of hepatitis C virus translation and subgenomic replication by siRNAs directed against highly conserved HCV sequence and cellular HCV cofactors. J Hepatol 43: 225-234. PMID: 15964661
35. Prabhu R, Garry RF, Dash S (2006) Small interfering RNA targeted to stem-loop II of the 5′ untranslated region effectively inhibits expression of six HCV genotypes. Virol J 3: 100. PMID: 17129382
36. Sen A, Steele R, Ghosh AK, Basu A, Ray R, et al. (2003) Inhibition of hepatitis C virus protein expression by RNA interference. Virus Res 96: 27-35. PMID: 12951263
37. Fraser CS, Doudna J a (2007) Structural and mechanistic insights into hepatitis C viral translation initiation. NatRevMicrobiol 5: 29-38.
38. Chevalier C, Saulnier A, Benureau Y, Fléchet D, Delgrange D, et al. (2007) Inhibition of hepatitis C virus infection in cell culture by small interfering RNAs. Mol Ther 15: 1452-1462. PMID: 17505476
39. Foster DJ, Barros S, Duncan R, Shaikh S, Cantley W, et al. (2012) Comprehensive evaluation of canonical versus Dicer-substrate siRNA in vitro and in vivo. RNA 18: 557-568. doi: 10.1261/rna.031120.111 PMID: 22294662
40. Liu M, Ding H, Zhao P, Qin Z-L, Gao J, et al. (2006) RNA interference effectively inhibits mRNA accumulation and protein expression of hepatitis C virus core and E2 genes in human cells. Biosci Biotechnol Biochem 70: 2049-2055. PMID: 16960393
41. Liu X, Jiang F, Kalidas S, Smith D, Liu Q (2006) Dicer-2 and R2D2 coordinately bind siRNA to promote assembly of the siRISC complexes. RNA 12: 1514-1520. PMID: 16775303
42. Salomon W, Bulock K, Lapierre J, Pavco P, Woolf T, et al. (2010) Modified dsRNAs that are not processed by Dicer maintain potency and are incorporated into the RISC. Nucleic Acids Res 38: 3771-3779. doi: 10.1093/nar/gkq055 PMID: 20167638
43. Gvozdeva O V, Dovydenko IS, Venyaminova AG, Zenkova MA, Vlassov V V, et al. (2014) 42- and 63-bp anti-MDR1-siRNAs bearing 2′-OMe modifications in nuclease-sensitive sites induce specific and potent gene silencing. FEBS Lett 588: 1037-1043. doi: 10.1016/j.febslet.2014.02.015 PMID: 24561194
44. Prabhu R, Vittal P, Yin Q, Flemington E, Garry R, et al. (2005) Small interfering RNA effectively inhibits protein expression and negative strand RNA synthesis from a full-length hepatitis C virus clone. J Med Virol 76: 511-519. PMID: 15977238
45. Takigawa Y, Nagano-Fujii M, Deng L, Hidajat R, Tanaka M, et al. (2004) Suppression of hepatitis C virus replicon by RNA interference directed against the NS3 and NS5B regions of the viral genome. Microbiol Immunol 48: 591-598. PMID: 15322339
46. Wilson JA, Richardson CD (2005) Hepatitis C virus replicons escape RNA interference induced by a short interfering RNA directed against the NS5b coding region. J Virol 79: 7050-7058. PMID: 15890944
47. Trejo-Avila L, Elizondo-González R, Trujillo-Murillo KDC, Zapata-Benavides P, Rodríguez-Padilla C, et al. (n.d.) Antiviral therapy: inhibition of Hepatitis C Virus expression by RNA interference directed against the NS5B region of the viral genome. Ann Hepatol 6: 174-180. PMID: 17786145
48. Kim M, Shin D, Kim SI, Park M (2006) Inhibition of hepatitis C virus gene expression by small interfering RNAs using a tri-cistronic full-length viral replicon and a transient mouse model. Virus Res 122: 1-10. PMID: 16979254
49. Amarzguioui M, Prydz H (2004) An algorithm for selection of functional siRNA sequences. Biochem Biophys Res Commun 316: 1050-1058. PMID: 15044091
50. Reynolds A, Leake D, Boese Q, Scaringe S, Marshall WS, et al. (2004) Rational siRNA design for RNA interference. Nat Biotechnol 22: 326-330. PMID: 14758366
51. Ui-Tei K, Naito Y, Takahashi F, Haraguchi T, Ohki-Hamazaki H, et al. (2004) Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference. Nucleic Acids Res 32: 936-948. PMID: 14769950
52. Holland JJ, De La Torre JC, Steinhauer DA (1992) RNA virus populations as quasispecies. Curr Top Microbiol Immunol 176: 1-20. PMID: 1600748
53. Elbashir SM, Lendeckel W, Tuschl T (2001) RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev 15: 188-200. PMID: 11157775
54. Berkhout B, Das AT (2012) HIV-1 Escape From RNAi Antivirals: Yet Another Houdini Action? Mol Ther Nucleic Acids 1: e26. doi: 10.1038/mtna.2012.22 PMID: 23344078
55. Haasnoot J, Westerhout EM, Berkhout B (2007) RNA interference against viruses: strike and counterstrike. 25. PMID: 18066040